Hong Kong's experience on the use of extracorporeal membrane oxygenation for the treatment of influenza A (H1N1)

Hong Kong Medical Journal

Volumn 16, Issue 6, 2010, Pages 447-454

  Chan, Kenny K C ^a   Lee, K L ^b   Lam, Philip K N ^c   Law, K I ^b   Joynt, Gavin M ^c   Yan, W W ^a  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

^b UNITED CHRISTIAN HOSPITAL   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Extracorporeal membrane oxygenation; H1N1 subtype; Influenza A virus; Intensive care units; Respiratory insufficiency

Indexed keywords

ACETYLCYSTEINE; ANTIINFECTIVE AGENT; HYDROCORTISONE; HYPERIMMUNE GLOBULIN; METHYLPREDNISOLONE; NITRIC OXIDE; OSELTAMIVIR; PROSTACYCLIN; SELENIUM; ZANAMIVIR; ZINC;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; CONTROLLED STUDY; CONVALESCENCE; DEATH; EXTRACORPOREAL OXYGENATION; FEMALE; HEMOLYSIS; HIGH FREQUENCY VENTILATION; HONG KONG; HOSPITAL INFECTION; HUMAN; INFLUENZA A (H1N1); INTENSIVE CARE UNIT; LENGTH OF STAY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; OBSERVATIONAL STUDY; PLASMA TRANSFUSION; RETROSPECTIVE STUDY; SEPSIS; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCAL PNEUMONIA; URINARY TRACT INFECTION;

ADULT; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 79951485481     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Sihoe AD, Ng VM, Liu RW, Cheng LC. Pulmonary alveolar proteinosis in extremis: the case for aggressive whole lung lavage with extracorporeal membrane oxygenation support. Heart Lung Circ 2008;17:69-72.
2. Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009;374:1351-63.
3. Torres JP, O'Ryan M, Herve B, et al. Impact of the novel influenza A (H1N1) during the 2009 autumn-winter season in a large hospital setting in Santiago, Chile. Clin Infect Dis 2010;50:860-8.
4. Parcevaux M, Antok E, Boisson V, Grabel C, Bugnon O, Winer A. Acute respiratory distress due to Influenza A (H1N1) S-OIV and extracorporeal oxygenation: the benefit of a multidisciplinary care network [in French]. Ann Fr Anesth Reanim 2010;29:145-8.
5. Buckley E, Sidebotham D, McGeorge A, Roberts S, Allen SJ, Beca J. Extracorporeal membrane oxygenation for cardiorespiratory failure in four patients with pandemic H1N1 2009 influenza virus and secondary bacterial infection. Br J Anaesth 2010;104:326-9.
6. Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators, Davies A, Jones D, Bailey M, et al. Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA 2009;302:1888-95.
7. Flagg A, Danziger-Isakov L, Foster C, et al. Novel 2009 H1N1 influenza virus infection requiring extracorporeal membrane oxygenation in a pediatric heart transplant recipient. J Heart Lung Transplant 2010;29:582-4.
8. Grasselli G, Foti G, Patroniti N, et al. A case of ARDS associated with influenza A - H1N1 infection treated with extracorporeal respiratory support. Minerva Anestesiol 2009;75:741-5.
9. Kao TM, Wang CH, Chen YC, Ko WJ, Chang SC. The first case of severe novel H1N1 influenza successfully rescued by extracorporeal membrane oxygenation in Taiwan. J Formos Med Assoc 2009;108:894-8.
10. Weber SA, Ostermann A, Pohl C. Fulminant, life-threatening influenza A/H1N1 virus infection [in German]. Dtsch Med Wochenschr 2009;134:2447-50.
11. Freed DH, Henzler D, White CW, et al. Extracorporeal lung support for patients who had severe respiratory failure secondary to influenza A (H1N1) 2009 infection in Canada. Can J Anaesth 2010;57:240-7.
12. Sigurdsson GH, Möller AD, Kristinsson B, et al. Intensive care patients with influenza A (H1N1) infection in Iceland 2009 [in Icelandic]. Laeknabladid 2010;96:83-90.
13. Liong T, Lee KL, Poon YS, et al. The first novel influenza A (H1N1) fatality despite antiviral treatment and extracorporeal membrane oxygenation in Hong Kong. Hong Kong Med J 2009;15:381-4.
14. Use of hyperimmune intravenous immunoglobulin to treat serious human swine influenza infections. University of Hong Kong website: http://web3.hku.hk/facmed/hkumed/doc_download.php?id=33&post_date=26Aug092009. Accessed 30 Mar 2010.
15. Nakamura K, Schwartz BS, Lindegårdh N, Keh C, Guglielmo BJ. Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection. Clin Infect Dis 2010;50:e47-9.
16. Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005;172:1041-6.
17. ANZIC Influenza Investigators, Webb SA, Pettilä V, Seppelt I, et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009;361:1925-34.
18. Chrissis MB, Konrad M, Shrum S. CMMI: guidelines for process integration and product improvement. 2nd ed. Upper Saddle River, NJ: Addison-Wesley; 2007.
19. Forrester EC, Buteau BL, Shrum S. CMMI for services: guidelines for superior service. Upper Saddle River, NJ: Addison-Wesley; 2010.
20. Ji B, Undar A. An evaluation of the benefits of pulsatile versus nonpulsatile perfusion during cardiopulmonary bypass procedures in pediatric and adult cardiac patients. ASAIO J 2006;52:357-61.